secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001062993-25-013266
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma hires Deloitte to find out-licensing partner for D-MNA (BCC)
---------------------------------------------------------------------------

- Deloitte appointed exclusive lead financial adviser for out-licensing D-MNA for basal cell carcinoma.
- Company will pay Deloitte retainer plus contingent success fee if a transaction closes.
- Engagement letter signed July 29, 2025; no partner identified yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/0001062993-25-013266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-25-013266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer